Selected article for: "cellular protein and therapeutic strategy"
Author: Park, Jinyoung; Cho, Jinhong; Song, Eun Joo
Title: Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
  • Cord-id: m212mmgk
  • Document date: 2020_11_9
    • ID: m212mmgk
    Snippet: The ubiquitin–proteasome system (UPS) plays an important role in the cellular processes for protein quality control and homeostasis. Dysregulation of the UPS has been implicated in numerous diseases, including cancer. Indeed, components of UPS are frequently mutated or abnormally expressed in various cancers. Since Bortezomib, a proteasome inhibitor, received FDA approval for the treatment of multiple myeloma and mantle cell lymphoma, increasing numbers of researchers have been seeking drugs t
    Document: The ubiquitin–proteasome system (UPS) plays an important role in the cellular processes for protein quality control and homeostasis. Dysregulation of the UPS has been implicated in numerous diseases, including cancer. Indeed, components of UPS are frequently mutated or abnormally expressed in various cancers. Since Bortezomib, a proteasome inhibitor, received FDA approval for the treatment of multiple myeloma and mantle cell lymphoma, increasing numbers of researchers have been seeking drugs targeting the UPS as a cancer therapeutic strategy. Here, we introduce the essential component of UPS, including ubiquitinating enzymes, deubiquitinating enzymes and 26S proteasome, and we summarize their targets and mechanisms that are crucial for tumorigenesis. In addition, we briefly discuss some UPS inhibitors, which are currently in clinical trials as cancer therapeutics.

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • accumulation lead and acute sars cov respiratory syndrome coronavirus: 1
    • active catalytic site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
    • active research field and acute sars cov respiratory syndrome coronavirus: 1, 2
    • active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and localization regulate: 1
    • acute sars cov respiratory syndrome coronavirus and localization regulate: 1